Morning Movers 02/13: (GNOM) (NEP) (REGN) Higher; (CHTP) Lower
13. 2. 2012 16:34 - Streetinsider.com
Complete Genomics Inc. (Nasdaq: GNOM) 36% HIGHER; announced today that it has been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing. Mayo Clinic researchers will now be able to employ Complete Genomics' sequencing service for some of its large-scale whole genome sequencing projects.
Chelsea Therapeutics International, Ltd. (Nasdaq: CHTP) 35.5% LOWER; announced that during a presentation at the 14th Annual BIO CEO and Investor Conference president and CEO, Dr. Simon Pedder, plans to provide an update regarding the company's New Drug Application (NDA) forT NORHERA™ (droxidopa), an overview of key issues identified
